Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Share-based Compensation (2016 - 2018)

Historic Share-based Compensation for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$1000.0.

  • Armata Pharmaceuticals' Share-based Compensation fell 10075.76% to -$1000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $142000.0, marking a year-over-year decrease of 7971.43%. This contributed to the annual value of $2.9 million for FY2024, which is 20842.22% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Share-based Compensation of -$1000.0 as of Q4 2018, which was down 10075.76% from $8000.0 recorded in Q3 2018.
  • Armata Pharmaceuticals' Share-based Compensation's 5-year high stood at $1.4 million during Q3 2014, with a 5-year trough of -$1000.0 in Q4 2018.
  • Moreover, its 5-year median value for Share-based Compensation was $160000.0 (2015), whereas its average is $262900.0.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Share-based Compensation soared by 146923.08% in 2016, and later tumbled by 10075.76% in 2018.
  • Armata Pharmaceuticals' Share-based Compensation (Quarter) stood at $61000.0 in 2014, then skyrocketed by 277.05% to $230000.0 in 2015, then rose by 29.13% to $297000.0 in 2016, then tumbled by 55.56% to $132000.0 in 2017, then tumbled by 100.76% to -$1000.0 in 2018.
  • Its last three reported values are -$1000.0 in Q4 2018, $8000.0 for Q3 2018, and $13000.0 during Q2 2018.